SynthesisJournal of gastrointestinal cancer2025

Efficacy and Safety of Dual Therapy with HER2-inhibitors (Pertuzumab and Trastuzumab) in Gastric or Gastroesophageal Tumors: A Systematic Review and Meta-analysis.

Geraldo Lucas Lopes Costa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.